| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |